GSA Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,982
Closed -$537K 1300
2020
Q1
$537K Sell
5,982
-4,230
-41% -$415K 0.14% 139
2019
Q4
$1.1M Sell
10,212
-6,388
-38% -$683K 0.13% 170
2019
Q3
$1.63M Buy
+16,600
New +$1.87M 0.22% 41
2019
Q1
Sell
-43,500
Closed -$4.24M 1797
2018
Q4
$4.24M Buy
+43,500
New +$5.14M 0.49% 13
2018
Q3
Sell
-2,203
Closed -$274K 2014
2018
Q2
$274K Sell
2,203
-12,977
-85% -$1.52M 0.01% 1413
2018
Q1
$1.69M Buy
+15,180
New +$1.81M 0.09% 368
2017
Q4
Sell
-3,836
Closed -$538K 1917
2017
Q3
$538K Buy
3,836
+1,482
+63% +$201K 0.04% 921
2017
Q2
$286K Sell
2,354
-37,209
-94% -$4.33M 0.02% 1302
2017
Q1
$4.8M Buy
39,563
+37,872
+2,240% +$4.88M 0.26% 19
2016
Q4
$207K Sell
1,691
-16,591
-91% -$2.03M 0.01% 1582
2016
Q3
$2.24M Buy
18,282
+5,090
+39% +$655K 0.12% 203
2016
Q2
$1.54M Buy
13,192
+1,038
+9% +$147K 0.09% 367
2016
Q1
$1.69M Buy
12,154
+4,955
+69% +$728K 0.11% 256
2015
Q4
$1.37M Sell
7,199
-46,636
-87% -$8.15M 0.07% 475
2015
Q3
$8.42M Buy
53,835
+50,750
+1,645% +$9.26M 0.41% 16
2015
Q2
$558K Sell
3,085
-18,204
-86% -$3.14M 0.02% 1283
2015
Q1
$3.69M Buy
21,289
+4,139
+24% +$749K 0.15% 102
2014
Q4
$3.17M Buy
17,150
+4,062
+31% +$753K 0.22% 47
2014
Q3
$2.17M Sell
13,088
-79,907
-86% -$13.1M 0.11% 176
2014
Q2
$14.5M Buy
92,995
+75,127
+420% +$11.9M 0.65% 6
2014
Q1
$2.72M Buy
+17,868
New +$2.84M 0.19% 99

Other funds holding ALXN